Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 193

Sort by

Sort Order Select

Journal Articles

Synthetic Lethal Interaction between Apto-253 and IDH1/2 Mutations

Cheng-Yu Tsai, PhD, Hongying Zhang, MD PhD, William G Rice, PhD, Stephen B Howell, MD

Blood (2019) 134 (Supplement_1): 5755.

https://doi.org/10.1182/blood-2019-123571

Published: 2019

Journal Articles

Autism-Associated Chromatin Remodeler CHD8 Governs the Survival and Differentiation of Hematopoietic Stem/Progenitor Cells

Zhaowei Tu, PhD, Chen Wang, MSc, Chuntao Zhao, PhD, Lei Huang, PhD, Nathan Salomonis, PhD, Richard Q Lu, PhD, Yi Zheng, PhD

Blood (2019) 134 (Supplement_1): 1191.

https://doi.org/10.1182/blood-2019-127313

Published: 2019

Journal Articles

ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations

Nora E Rahmani, MD, Nandini Ramachandra, Tushar D Bhagat, PhD, Shanisha Gordon, Kith Pradhan, PhD, Bianca Rivera Pena, Mohammad Kazemi, Orsi Giricz, PhD, Shahina Maqbool, Raul Olea, Hamid Dolatshad, Vickram Tittrea, Dharamveer Tatwavedi, Shalini Singh, Andrea Pellagatti, Jacqueline Boultwood, Amit Verma, MBBS

Blood (2019) 134 (Supplement_1): 2989.

https://doi.org/10.1182/blood-2019-126850

Published: 2019

Journal Articles

Whole Genome Bisulfite Sequencing of 63 Primary AML Samples Identifies a Unique DNA Hypermethylation Signature for Mutant IDH1/2 Cases That Is Different from That of TET2 Mutant AML

Ellie Wilson, BS, Nichole Helton, Catrina Fronick, BS, Robert Fulton, MS, John S. Welch, MD PhD, Timothy J Ley, MD, David H Spencer, MD

Blood (2019) 134 (Supplement_1): 3755.

https://doi.org/10.1182/blood-2019-122340

Published: 2019

Journal Articles

Significant Features of DNA Methylation at Bivalent Promotor and Repressed Polycomb Regions in Pediatric AML-the Jccg Study, JPLSG AML-05-

Blood (2019) 134 (Supplement_1): 2739.

https://doi.org/10.1182/blood-2019-125025

Published: 2019

Journal Articles

B Cell Restricted Expression of Mutated IKZF3 modulates BCR Signaling and Homing Pathways in a Mouse Model of CLL

Gregory Lazarian, PharmD, Shanye Yin, PhD, Elisa Ten Hacken, PhD, Tomasz Sewastianik, MSc,PhD, Alba Font-tello, PhD, Heather Joyal, Elizabeth Witten, Mei Zheng, Christopher J. Ott, PhD, Donna S Neuberg, ScD, Lili Wang, MD PhD, Ruben D. Carrasco, MD PhD, Catherine J. Wu, MD

Blood (2019) 134 (Supplement_1): 848.

https://doi.org/10.1182/blood-2019-123963

Published: 2019

Journal Articles

Bach1 Inhibitors Reduce Stasis in Townes Sickle Cell Mouse Model

John D Belcher, PhD, Margaret Biddle, PhD, Domi Stickens, PhD, Lyndsay Olson, Eric Bell, Chunsheng Chen, Fuad Abdulla, Julia Nguyen, Zachary Monroe Kiser, BS, PhD, Jacob Lloyd, MD, Gregory M Vercellotti, MD

Blood (2019) 134 (Supplement_1): 983.

https://doi.org/10.1182/blood-2019-127300

Published: 2019

Journal Articles

Comprehensive Genomic Analysis of IDH Inhibitor-Treated AML Samples Delineates Molecular Mechanisms of Differentiation and Heterogeneous Patterns of Acquired Resistance

Blood (2018) 132 (Supplement 1): 441.

https://doi.org/10.1182/blood-2018-99-116383

Published: 2018

Journal Articles

RAB31-Mediated Endosomal Trafficking Is Defective in RUNX1 Haplodeficiency

Gauthami S. Jalagadugula, PhD, Guangfen Mao, MD, Lawrence E. Goldfinger, PhD, Jeremy Wurtzel, MS, Michele P. Lambert, MD, Angara Koneti Rao, MBBS

Blood (2018) 132 (Supplement 1): 519.

https://doi.org/10.1182/blood-2018-99-118312

Published: 2018

Journal Articles

Long Intergenic Non-Coding RNAs Unambiguously Classify AML Subgroups

Wencke Walter, PhD, Jesús María Hernández, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Manja Meggendorfer, PhD

Blood (2018) 132 (Supplement 1): 5112.

https://doi.org/10.1182/blood-2018-99-118276

Published: 2018

Journal Articles

Downstream Pathway of AML1-ETO Targeted ARHGEF12 Might be Targetable for Rock Inhibitor to Improve Therapy Outcome

Yangyang Xie, Ruichi Wu, Xiaoxiao Chen, Xiao-Jian Sun, PhD, Shuhong Shen, MD PhD

Blood (2018) 132 (Supplement 1): 3914.

https://doi.org/10.1182/blood-2018-99-117845

Published: 2018

Journal Articles

CRISPR Activation Screen for Drivers of MM Cell Proliferation

Huihui Tang, PhD, Ricardo De Matos Simoes, PhD, Ryosuke Shirasaki, MD PhD, Olga Dashevsky, PhD, Brian Glassner, PhD, Sondra L. Downey-Kopyscinski, PhD, Sara Gandolfi, MD, Michal Sheffer, PhD, Megan Bariteau, BSc, John G Doench, PhD, Constantine S. Mitsiades, MD PhD

Blood (2018) 132 (Supplement 1): 3197.

https://doi.org/10.1182/blood-2018-99-118712

Published: 2018

Journal Articles

The Critical Role of HDAC1-IRF4-Pim-2 Axis in Myeloma Cell Growth and Survival: Therapeutic Impacts of Targeting the HDAC1-IRF4-Pim-2 Axis

Takeshi Harada, MD PhD, Asuka Oda, PhD, Yohann Grondin, PhD, Jumpei Teramachi, DDS, PhD, Ariunzaya Bat-Erdene, MD PhD, Masami Iwasa, MD, Masahiro Oura, MD, Shingen Nakamura, MD PhD, Kumiko Kagawa, MD PhD, Yasunobu Okamoto, MD, Kimiko Sogabe, MD, Shiro Fujii, MD, Hirokazu Miki, MD PhD, Shuji Ozaki, MD PhD, Teru Hideshima, MD PhD, Kenneth C. Anderson, MD, Masahiro Abe, MD PhD

Blood (2018) 132 (Supplement 1): 1939.

https://doi.org/10.1182/blood-2018-99-114086

Published: 2018

Journal Articles

Defining the Transcriptional Code That Specifies Sinusoidal Endothelial Cells in the HSPC Niche

Elliott J. Hagedorn, PhD, Julie R. Perlin, PhD, Clara Mao, Shelby E. Redfield, B.S., Madeleine L. Daily, B.S., Samantha H. Collins, B.S., Christopher R. D'Amato, B.S., Raquel Riquelme, Brian Li, B.S., Samuel J. Wattrus, B.S., Karoline Holler, B.S., Alexander van Oudenaarden, PhD, Jan Philipp Junker, PhD, Leonard I. Zon, MD

Blood (2017) 130 (Supplement 1): 136.

https://doi.org/10.1182/blood.V130.Suppl_1.136.136

Published: 2017

Journal Articles

AML Differentially Alters Fate and Function of Mesenchymal Stem- and Osteolineage Cells in the Leukemic Niche

Ben Doron, BS, Sherif Abdelhamed, PhD, Ryan M Mulqueen, B.S., Julja Burchard, M.S., Andrew Adey, PhD, Peter Kurre, MD

Blood (2017) 130 (Supplement 1): 1197.

https://doi.org/10.1182/blood.V130.Suppl_1.1197.1197

Published: 2017

Journal Articles

The Phosphorylation State of Ezh2 Determines Its Capacity to Maintain CD8 + Memory T Cells for Antitumor Immunity

Shan He, PhD, Yongnian Liu, Lijun Meng, Hongxing SUN, Ying Wang, Yun Ji, Janaki Purushe, BS, Pan Chen, Changhong Li, Jozef Madzo, Jean-Pierre Issa, MD, Jonathan Soboloff, Ran Reshef, MD, Bethany Moore, Luca Gattinoni, Yi Zhang, MD

Blood (2017) 130 (Supplement 1): 4455.

https://doi.org/10.1182/blood.V130.Suppl_1.4455.4455

Published: 2017

Journal Articles

Identification of SETBP1 As an Epigenetic Hub Protein That Induces the Transcription of a Network of Development-Related Genes

Blood (2017) 130 (Supplement 1): 4980.

https://doi.org/10.1182/blood.V130.Suppl_1.4980.4980

Published: 2017

Journal Articles

Fetal Inactivation of the Nuclear Interacting SET Domain Protein 1 Impairs Terminal Erythroid Maturation and Results in Acute Erythroleukemia in Mice

Katharina Leonards, PhD, Marwa Almosailleakh, MSc, Samantha Tauchmann, Msc, Helene Mereau, PhD, Sabine Juge, Matheus Filgueira Bezerra, MSc, Susanne Kasper, PhD, Robert Ivanek, PhD, Alexandar Tzankov, Antoine HFM Peters, PhD, Juerg Schwaller, MD

Blood (2017) 130 (Supplement 1): 713.

https://doi.org/10.1182/blood.V130.Suppl_1.713.713

Published: 2017

Journal Articles

LSD1 Inhibition Exerts Its Anti-Leukemic Effect By Recommissioning PU.1- and C/Ebpα-Dependent Enhancers in AML

Monica Cusan, MD, Sheng Cai, MD PhD, Helai P Mohammad, PhD, Andrei V. Krivtsov, PhD, Alan Chramiec, Evangelia Loizou, Daniel G. Tenen, MD, Min Ye, PhD, Britta Will, PhD, Ulrich G. Steidl, MDPhD, Ryan G. Kruger, PhD, Richard Koche, PhD, Scott Armstrong, MD PhD

Blood (2017) 130 (Supplement 1): 242.

https://doi.org/10.1182/blood.V130.Suppl_1.242.242

Published: 2017

Journal Articles

Defective Rab1b Related Megakaryocytic ER-to-Golgi Transport in RUNX1 Haplodeficiency

Gauthami S. Jalagadugula, PhD, Lawrence E. Goldfinger, PhD, Guangfen Mao, MD, Angara Koneti Rao, MD

Blood (2017) 130 (Supplement 1): 2333.

https://doi.org/10.1182/blood.V130.Suppl_1.2333.2333

Published: 2017

NARROW

Synthetic Lethal Interaction between Apto-253 and IDH1/2 Mutations

Autism-Associated Chromatin Remodeler CHD8 Governs the Survival and Differentiation of Hematopoietic Stem/Progenitor Cells

ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations

Whole Genome Bisulfite Sequencing of 63 Primary AML Samples Identifies a Unique DNA Hypermethylation Signature for Mutant IDH1/2 Cases That Is Different from That of TET2 Mutant AML

Significant Features of DNA Methylation at Bivalent Promotor and Repressed Polycomb Regions in Pediatric AML-the Jccg Study, JPLSG AML-05-

B Cell Restricted Expression of Mutated IKZF3 modulates BCR Signaling and Homing Pathways in a Mouse Model of CLL

Bach1 Inhibitors Reduce Stasis in Townes Sickle Cell Mouse Model

Comprehensive Genomic Analysis of IDH Inhibitor-Treated AML Samples Delineates Molecular Mechanisms of Differentiation and Heterogeneous Patterns of Acquired Resistance

RAB31-Mediated Endosomal Trafficking Is Defective in RUNX1 Haplodeficiency

Long Intergenic Non-Coding RNAs Unambiguously Classify AML Subgroups

Downstream Pathway of AML1-ETO Targeted ARHGEF12 Might be Targetable for Rock Inhibitor to Improve Therapy Outcome

CRISPR Activation Screen for Drivers of MM Cell Proliferation

The Critical Role of HDAC1-IRF4-Pim-2 Axis in Myeloma Cell Growth and Survival: Therapeutic Impacts of Targeting the HDAC1-IRF4-Pim-2 Axis

Defining the Transcriptional Code That Specifies Sinusoidal Endothelial Cells in the HSPC Niche

AML Differentially Alters Fate and Function of Mesenchymal Stem- and Osteolineage Cells in the Leukemic Niche

The Phosphorylation State of Ezh2 Determines Its Capacity to Maintain CD8 + Memory T Cells for Antitumor Immunity

Identification of SETBP1 As an Epigenetic Hub Protein That Induces the Transcription of a Network of Development-Related Genes

Fetal Inactivation of the Nuclear Interacting SET Domain Protein 1 Impairs Terminal Erythroid Maturation and Results in Acute Erythroleukemia in Mice

LSD1 Inhibition Exerts Its Anti-Leukemic Effect By Recommissioning PU.1- and C/Ebpα-Dependent Enhancers in AML

Defective Rab1b Related Megakaryocytic ER-to-Golgi Transport in RUNX1 Haplodeficiency

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only